Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.43 |
| ▸ | GPR3 | P46089 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CA12 | O43570 | 1/20 | 0.30 |
| ▸ | CA1 | P00915 | 1/20 | 0.30 |
| ▸ | CA2 | P00918 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
| ▸ | NOS3 | P29474 | 1/20 | 0.30 |
| ▸ | NOS2 | P35228 | 1/20 | 0.30 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1782628 | 0.74 | LMNA (0.33) | ALDH1A1KDM4ELMNA | |
| SCHEMBL28960027 | 0.69 | STK17B (0.37) | ALDH1A1L3MBTL1KDM4ETDP1 | |
| SCHEMBL30026278 | 0.69 | STK17B (0.37) | ALDH1A1L3MBTL1KDM4ETDP1 | |
| SCHEMBL28960028 | 0.69 | STK17B (0.37) | ALDH1A1L3MBTL1KDM4ETDP1 | |
| SCHEMBL25527501 | 0.68 | POLB (0.44) | TSHRALDH1A1L3MBTL1KDM4ELMNA | |
| SCHEMBL7771836 | 0.68 | CA12 (0.32) | CA12CA9 | |
| SCHEMBL7771834 | 0.68 | AKR1B1 (0.35) | CYP1A2PKMTSHRCA12CA2 | |
| SCHEMBL3380497 | 0.68 | HSP90AA1 (0.40) | GPR3PKMTSHRCA12CA1 | |
| SCHEMBL299692 | 0.65 | ALDH1A1 (0.50) | GPR3PKMTSHRALDH1A1L3MBTL1 | |
| SCHEMBL29695488 | 0.65 | ALDH1A1 (0.50) | GPR3PKMTSHRALDH1A1L3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8173641-B2 | 4-amino-1,2,3-benzoxathiazine-derivatives as pesticides | BAYER CROPSCIENCE AG (DE) | 2012-05-08 | — | — | US | disclosed |
| US-8173641-B2 | 4-amino-1,2,3-benzoxathiazine-derivatives as pesticides | BAYER CROPSCIENCE AG (DE) | 2012-05-08 | — | — | US | disclosed |
| US-8173641-B2 | 4-amino-1,2,3-benzoxathiazine-derivatives as pesticides | BAYER CROPSCIENCE AG (DE) | 2012-05-08 | — | — | US | disclosed |
| US-20110118240-A2 | 4-Amino-1,2,3-Benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2011-05-19 | — | — | US | disclosed |
| US-20110118240-A2 | 4-Amino-1,2,3-Benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2011-05-19 | — | — | US | disclosed |
| US-20110118240-A2 | 4-Amino-1,2,3-Benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2011-05-19 | — | — | US | disclosed |
| US-20100267703-A1 | 4-Amino-1,2,3-benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2010-10-21 | — | — | US | disclosed |
| US-20100267703-A1 | 4-Amino-1,2,3-benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2010-10-21 | — | — | US | disclosed |
| US-20100267703-A1 | 4-Amino-1,2,3-benzoxathiazine-Derivatives as Pesticides | BAYER CROPSCIENCE AG (DE) | 2010-10-21 | — | — | US | disclosed |
| WO-2010072310-A1 | 4-AMINO-1,2,3- BENZOXATHIAZINE DERIVATIVES AS PESTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2010-07-01 | — | — | WO | disclosed |
| EP-2196461-A1 | 4-Amino-1,2,3-benzoxathiazine-derivatives as pesticides | Bayer CropScience AG (DE) | 2010-06-16 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100267703-A1 | 4-Amino-1,2,3-benzoxathiazine-Derivatives as Pesticides | P2RX5, SLC1A5, P2RX4 | CYP1A2 1098/4885CYP2D6 2385/4885GPR3 1280/4885 |
| US-20110118240-A2 | 4-Amino-1,2,3-Benzoxathiazine-Derivatives as Pesticides | P2RX5, P2RX4, SLC1A5 | CYP1A2 934/4885CYP2D6 1763/4885GPR3 1142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.